Venous Thrombosis Trials in holon, israel
Conditions / Venous Thrombosis / holon, israel
8 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00097357 | BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery | COMPLETED | PHASE2/PHASE3 |
| NCT00440193 | Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study | COMPLETED | PHASE3 |
| NCT00643201 | Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism | COMPLETED | PHASE3 |
| NCT00786422 | Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer | COMPLETED | PHASE2 |
| NCT00633893 | Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism | COMPLETED | PHASE3 |
| NCT00839163 | Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT) | COMPLETED | PHASE2 |
| NCT02064439 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | COMPLETED | PHASE3 |
| NCT00986154 | Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). | COMPLETED | PHASE3 |